Matches in Wikidata for { <http://www.wikidata.org/entity/Q58088020> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q58088020 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q58088020 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58088020 description "scientific article published on 31 October 2018" @default.
- Q58088020 description "wetenschappelijk artikel" @default.
- Q58088020 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q58088020 name "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 name "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 type Item @default.
- Q58088020 label "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 label "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 altLabel "Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study" @default.
- Q58088020 prefLabel "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 prefLabel "Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study" @default.
- Q58088020 P1433 Q58088020-B3CD603E-3078-422F-9133-F0E1167D2012 @default.
- Q58088020 P1476 Q58088020-BB8735A1-6448-4236-A22B-916AE215D28B @default.
- Q58088020 P2093 Q58088020-330845DC-C18A-42F4-A876-DAD90FAD5362 @default.
- Q58088020 P2093 Q58088020-3C5F715A-1661-4E68-9193-14E16CA119B6 @default.
- Q58088020 P2093 Q58088020-49443901-1636-458C-B31B-A217C805763A @default.
- Q58088020 P2093 Q58088020-58BE60E0-7BB2-4F96-80C6-5169CE2C0542 @default.
- Q58088020 P2093 Q58088020-5D0C3A0E-E7A8-4E2C-A01D-6A02D35921D2 @default.
- Q58088020 P2093 Q58088020-9AE9E304-4280-4E32-98D0-786D3D29B929 @default.
- Q58088020 P2093 Q58088020-CDF76D9C-371B-41D9-81DB-6394B7313EDE @default.
- Q58088020 P2093 Q58088020-D830A417-4088-4604-A4F9-8940EBA6B2B3 @default.
- Q58088020 P2093 Q58088020-D868875E-4C57-4826-AB6A-221A2C1BC6F1 @default.
- Q58088020 P2093 Q58088020-D9856B16-7276-4BA3-B8F0-E4F1916E6BF3 @default.
- Q58088020 P2093 Q58088020-F6893AB5-DDE5-4E72-A35F-F7E78180813A @default.
- Q58088020 P2860 Q58088020-6401B6BF-7CD6-4B20-98AB-D8A39E793956 @default.
- Q58088020 P2860 Q58088020-8BD5B8C8-941E-4B47-B334-3FA8113C1FB5 @default.
- Q58088020 P2860 Q58088020-8D2C131C-D1F9-4BF1-8F2C-8DAE503317A4 @default.
- Q58088020 P2860 Q58088020-9F22A32F-BAC2-4C68-9825-C6C87FD315F2 @default.
- Q58088020 P2860 Q58088020-B9C92C56-2010-4D79-AF98-B35A0E40FA24 @default.
- Q58088020 P2860 Q58088020-BE044A26-A87C-4709-8C4D-00A4E36A1485 @default.
- Q58088020 P2860 Q58088020-DBF8DFDD-822D-4F95-AB28-5431D0E3DD92 @default.
- Q58088020 P2860 Q58088020-E98B6968-9CF4-4DEF-A864-C879F322E9A7 @default.
- Q58088020 P2860 Q58088020-F23399F4-8E09-41D0-9549-B1AF852D834C @default.
- Q58088020 P2860 Q58088020-F84DE660-023F-4995-9A9D-ED6E8BF95006 @default.
- Q58088020 P304 Q58088020-88C227A3-98FD-4D2B-86DA-F83D9FA5609F @default.
- Q58088020 P31 Q58088020-2EC77B59-9573-4122-AE86-3D83C421E77B @default.
- Q58088020 P356 Q58088020-65515453-270E-429E-B7D6-3C88C6F4358A @default.
- Q58088020 P407 Q58088020-33E8B1C0-A1C9-402B-955C-4754F7841704 @default.
- Q58088020 P433 Q58088020-F5F0207B-3021-42CE-A402-BDEFFC11CFEB @default.
- Q58088020 P478 Q58088020-8ED0EA0F-BCD8-4E91-9E92-CDF7AB5998FB @default.
- Q58088020 P50 Q58088020-7DDE0C92-C20F-41E4-8C6A-6A09E0DB91C8 @default.
- Q58088020 P577 Q58088020-5739AFAF-FA3D-4A45-BC50-CAE004E28C8C @default.
- Q58088020 P698 Q58088020-D91AF944-A790-485A-8263-3862B32B7A48 @default.
- Q58088020 P921 Q58088020-2AEE2661-7B49-4F7B-A544-FDE3183AD4A5 @default.
- Q58088020 P921 Q58088020-469DDC1A-7A21-481E-9093-791678811510 @default.
- Q58088020 P921 Q58088020-7A6DC1A2-4CED-4084-867B-6A0E078601F9 @default.
- Q58088020 P921 Q58088020-9C614091-DC24-4C72-B7A2-996CEAA1D184 @default.
- Q58088020 P932 Q58088020-5CC30046-C7A2-4404-9BCA-EE33C7587F70 @default.
- Q58088020 P356 HAEMATOL.2018.196899 @default.
- Q58088020 P698 30381303 @default.
- Q58088020 P1433 Q5638209 @default.
- Q58088020 P1476 "Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study" @default.
- Q58088020 P2093 "Anton Hagenbeek" @default.
- Q58088020 P2093 "Gustaaf van Imhoff" @default.
- Q58088020 P2093 "Hans Mooij" @default.
- Q58088020 P2093 "Harm van Tinteren" @default.
- Q58088020 P2093 "Josée Zijlstra" @default.
- Q58088020 P2093 "Marcel Nijland" @default.
- Q58088020 P2093 "Marie José Kersten" @default.
- Q58088020 P2093 "Marjolein Spiering" @default.
- Q58088020 P2093 "Pieternella Lugtenburg" @default.
- Q58088020 P2093 "Roberto Liu" @default.
- Q58088020 P2093 "Sanne Tonino" @default.
- Q58088020 P2860 Q26765151 @default.
- Q58088020 P2860 Q33344684 @default.
- Q58088020 P2860 Q33403209 @default.
- Q58088020 P2860 Q34147803 @default.
- Q58088020 P2860 Q36094726 @default.
- Q58088020 P2860 Q36264723 @default.
- Q58088020 P2860 Q36822162 @default.
- Q58088020 P2860 Q42384513 @default.
- Q58088020 P2860 Q47563175 @default.
- Q58088020 P2860 Q53026185 @default.
- Q58088020 P304 "e151-e153" @default.
- Q58088020 P31 Q13442814 @default.
- Q58088020 P356 "10.3324/HAEMATOL.2018.196899" @default.
- Q58088020 P407 Q1860 @default.
- Q58088020 P433 "4" @default.
- Q58088020 P478 "104" @default.
- Q58088020 P50 Q57612784 @default.
- Q58088020 P577 "2018-10-31T00:00:00Z" @default.
- Q58088020 P698 "30381303" @default.
- Q58088020 P921 Q180983 @default.
- Q58088020 P921 Q209369 @default.
- Q58088020 P921 Q412415 @default.
- Q58088020 P921 Q422252 @default.
- Q58088020 P932 "6442967" @default.